niacinamide has been researched along with Fallopian Tube Neoplasms in 2 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Fallopian Tube Neoplasms: Benign or malignant neoplasms of the FALLOPIAN TUBES. They are uncommon. If they develop, they may be located in the wall or within the lumen as a growth attached to the wall by a stalk.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was designed to evaluate the response and toxicity of sorafenib alone or when combined with carboplatin and paclitaxel in patients with platinum-sensitive, recurrent ovarian cancer, fallopian tube cancer, or primary peritoneal cancer (EOC)." | 2.79 | Randomized phase II trial of sorafenib alone or in combination with carboplatin/paclitaxel in women with recurrent platinum sensitive epithelial ovarian, peritoneal, or fallopian tube cancer. ( Dowlati, A; Eaton, S; Frasure, H; Fu, P; Fusco, N; Schwandt, A; von Gruenigen, VE; Waggoner, S; Wenham, RM; Wright, JJ, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schwandt, A | 1 |
| von Gruenigen, VE | 1 |
| Wenham, RM | 1 |
| Frasure, H | 1 |
| Eaton, S | 1 |
| Fusco, N | 1 |
| Fu, P | 1 |
| Wright, JJ | 1 |
| Dowlati, A | 1 |
| Waggoner, S | 1 |
| Schilder, RJ | 1 |
| Sill, MW | 1 |
| Lankes, HA | 1 |
| Gold, MA | 1 |
| Mannel, RS | 1 |
| Modesitt, SC | 1 |
| Hanjani, P | 1 |
| Bonebrake, AJ | 1 |
| Sood, AK | 1 |
| Godwin, AK | 1 |
| Hu, W | 1 |
| Alpaugh, RK | 1 |
2 trials available for niacinamide and Fallopian Tube Neoplasms
| Article | Year |
|---|---|
Randomized phase II trial of sorafenib alone or in combination with carboplatin/paclitaxel in women with recurrent platinum sensitive epithelial ovarian, peritoneal, or fallopian tube cancer.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, | 2014 |
A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: a Gynecologic Oncology Group study.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; DNA, Neoplasm; Fallopian Tube Neoplasms; Female; G | 2013 |